- Home
- PHAR vs HCSG Comparison
PHAR vs HCSG Comparison
Compare PHAR & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- HCSG
- Stock Information
- Founded
- PHAR 1988
- HCSG 1976
- Country
- PHAR Netherlands
- HCSG United States
- Employees
- PHAR N/A
- HCSG N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- HCSG Assisted Living Services
- Sector
- PHAR Health Care
- HCSG Health Care
- Exchange
- PHAR Nasdaq
- HCSG Nasdaq
- Market Cap
- PHAR 1.0B
- HCSG 1.1B
- IPO Year
- PHAR N/A
- HCSG N/A
- Fundamental
- Price
- PHAR $14.60
- HCSG $16.43
- Analyst Decision
- PHAR Strong Buy
- HCSG Strong Buy
- Analyst Count
- PHAR 3
- HCSG 4
- Target Price
- PHAR $30.00
- HCSG $16.25
- AVG Volume (30 Days)
- PHAR 11.5K
- HCSG 687.7K
- Earning Date
- PHAR 10-23-2025
- HCSG 10-22-2025
- Dividend Yield
- PHAR N/A
- HCSG N/A
- EPS Growth
- PHAR N/A
- HCSG N/A
- EPS
- PHAR N/A
- HCSG 0.14
- Revenue
- PHAR $339,836,000.00
- HCSG $1,772,114,000.00
- Revenue This Year
- PHAR $16.63
- HCSG $8.88
- Revenue Next Year
- PHAR $6.77
- HCSG $5.09
- P/E Ratio
- PHAR N/A
- HCSG $114.57
- Revenue Growth
- PHAR 22.44
- HCSG 5.17
- 52 Week Low
- PHAR $7.06
- HCSG $9.13
- 52 Week High
- PHAR $17.08
- HCSG $16.54
- Technical
- Relative Strength Index (RSI)
- PHAR 57.37
- HCSG 67.15
- Support Level
- PHAR $13.51
- HCSG $15.72
- Resistance Level
- PHAR $15.61
- HCSG $16.59
- Average True Range (ATR)
- PHAR 0.87
- HCSG 0.38
- MACD
- PHAR -0.06
- HCSG 0.03
- Stochastic Oscillator
- PHAR 59.37
- HCSG 86.26
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About HCSG Healthcare Services Group Inc.
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.